Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 108Lymphoma, Large B-Cell, Diffuse 97Lymphoma 86Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Lymphoma, Non-Hodgkin 37Lymphoma, Follicular 37Burkitt Lymphoma 36Leukemia 30Multiple Myeloma 29Lymphoma, Mantle-Cell 26Hodgkin Disease 25Lymphoma, T-Cell, Peripheral 20Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, Large-Cell, Anaplastic 15Lymphoma, B-Cell, Marginal Zone 15Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Neoplasm Metastasis 13Lymphoma, B-Cell 13Leukemia, Lymphocytic, Chronic, B-Cell 12Recurrence 11Neoplasms, Plasma Cell 11Immunoblastic Lymphadenopathy 11Lymphoma, T-Cell 8Dendritic Cell Sarcoma, Interdigitating 8Blast Crisis 8Neoplasms 7Enteropathy-Associated T-Cell Lymphoma 7Waldenstrom Macroglobulinemia 5Primary Myelofibrosis 5Myasthenia Gravis 5

Interventions

deltacortene 1Vincristine 1Rituximab 1Prednisone 1Methotrexate 1Hyaluronoglucosaminidase 1Etoposide 1Doxorubicin 1Cyclophosphamide 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Multi-centric Castleman's Disease × Prednisone × Clear all
NCT03864419 2024-01-03

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Fred Hutchinson Cancer Center

Phase 1 Terminated
18 enrolled
Lymphoid

Multi-centric Castleman's Disease, Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡